Italia markets open in 3 hours 21 minutes

Illumina, Inc. (0J8Z.L)

LSE - LSE Prezzo differito. Valuta in USD.
Aggiungi a watchlist
102,31+6,02 (+6,25%)
Alla chiusura: 07:13PM GMT
Schermo intero
Chiusura precedente96,29
Aperto0,00
Denaro0,00 x 0
Lettera0,00 x 0
Min-Max giorno0,00 - 0,00
Intervallo di 52 settimane
Volume13
Media Volume3.265
Capitalizzazione152,078M
Beta (5 anni mensile)1,16
Rapporto PE (ttm)0,22
EPS (ttm)4,55
Prossima data utili05 feb 2024 - 09 feb 2024
Rendimento e dividendo (futuro)N/D (N/D)
Data ex dividendoN/D
Stima target 1AN/D
  • GlobeNewswire

    Myriad Genetics and Illumina Achieve Milestones in Strategic Partnership to Support Biopharma Clinical Trials

    Myriad can conduct prospective clinical trials using Illumina’s TruSight Oncology Comprehensive Investigational Use Only testSALT LAKE CITY, Sept. 19, 2023 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc. (NASDAQ: MYGN), a leader in genetic testing and precision medicine, today announced two key milestones in its strategic partnership with Illumina Inc. (NASDAQ: ILMN), a global leader in DNA sequencing and array-based technologies, to advance and support clinical research for gene-based, targeted thera

  • GlobeNewswire

    Illumina and Myriad Genetics expand partnership to broaden access to HRD testing in the United States

    Strategic partnership offers a unique combination of diagnostic development and commercialization capabilities to the pharmaceutical industrySALT LAKE CITY, March 02, 2023 (GLOBE NEWSWIRE) -- Myriad Genetic, Inc. (NASDAQ: MYGN), a leader in genetic testing and precision medicine, and Illumina Inc. (NASDAQ: ILMN), a global leader in DNA sequencing and array-based technologies, today announced the expansion of a strategic partnership to broaden access to and availability of oncology homologous rec